ABATACEPT DELAYS THE DEVELOPMENT OF RA-CLINICAL RESULTS AFTER 18 MONTHS FROM THE RANDOMIZED, PLACEBO-CONTROLLED ARIAA STUDY IN RA-AT RISK PATIENTS

Rech J, Kleyer A, Ostergaard M, Hagen M, Valor L, Tascilar K, Krönke G, Schönau V, Kleinert S, Baraliakos X, Braun J, Fleck M, Rubbert-Roth A, Behrens F, Feuchtenberger M, Zaenker M, Kofler DM, Voll R, Glaser C, Hueber A, Feist E, Burmester GR, Karberg K, Strunk J, Canete JDD, Senolt L, Naredo E, Schett G (2022)

Publication Type: Conference contribution

Publication year: 2022

Journal

Annals of the Rheumatic Diseases BMJ Publishing Group

Publisher: BMJ PUBLISHING GROUP

City/Town: LONDON

Pages Range: 526-527

Conference Proceedings Title: ANNALS OF THE RHEUMATIC DISEASES

DOI: 10.1136/annrheumdis-2022-eular.1693

Authors with CRIS profile

Hans Jürgen Rech Department of Medicine 3 – Rheumatology and Immunology Arnd Kleyer Department of Medicine 3 – Rheumatology and Immunology Melanie Hagen Department of Medicine 3 – Rheumatology and Immunology Koray Tascilar Department of Medicine 3 – Rheumatology and Immunology Gerhard Krönke Professur für Translationale Immunologie Georg Schett Lehrstuhl für Innere Medizin III

Involved external institutions

Kantonsspital St.Gallen CH Switzerland (CH) Rigshospitalet DK Denmark (DK) HELIOS Kliniken DE Germany (DE) Universitätsklinikum Köln DE Germany (DE) Charité - Universitätsmedizin Berlin DE Germany (DE) Universitätsklinikum Freiburg DE Germany (DE) Ruhr-Universität Bochum (RUB) DE Germany (DE) Immanuel Klinikum Bernau DE Germany (DE) Krankenhaus Porz am Rhein DE Germany (DE) Universitätsklinikum Frankfurt am Main (KGU) DE Germany (DE) Hospital Universitario Fundación Jiménez Díaz ES Spain (ES) Hospital Clínic de Barcelona ES Spain (ES) Paracelsus Medizinische Privatuniversität, Nürnberg DE Germany (DE) Asklepios Kliniken DE Germany (DE) Rheumazentrum Ruhrgebiet DE Germany (DE)

How to cite

APA:

Rech, J., Kleyer, A., Ostergaard, M., Hagen, M., Valor, L., Tascilar, K.,... Schett, G. (2022). ABATACEPT DELAYS THE DEVELOPMENT OF RA-CLINICAL RESULTS AFTER 18 MONTHS FROM THE RANDOMIZED, PLACEBO-CONTROLLED ARIAA STUDY IN RA-AT RISK PATIENTS. In ANNALS OF THE RHEUMATIC DISEASES (pp. 526-527). LONDON: BMJ PUBLISHING GROUP.

MLA:

Rech, Jürgen, et al. "ABATACEPT DELAYS THE DEVELOPMENT OF RA-CLINICAL RESULTS AFTER 18 MONTHS FROM THE RANDOMIZED, PLACEBO-CONTROLLED ARIAA STUDY IN RA-AT RISK PATIENTS." Proceedings of the ANNALS OF THE RHEUMATIC DISEASES LONDON: BMJ PUBLISHING GROUP, 2022. 526-527.

BibTeX: Download